Concepedia

Joel Mermis

JM

10

Publications

600

Citations

10

H-Index

2007

Active since

Affiliations

University of Kansas Medical Center(Current)

University of Kansas

University of Colorado Denver

University of Washington

National Jewish Health

Joel Mermis is an author at University of Kansas Medical Center specializing in medicine, pharmacology, and engineering.

ORCID

Top concepts

Publications per year

2007–2025

10

Publications

10

Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics

Sushma Komakula, Sumita Khatri, Joel Mermis et al. · Respiratory Research · 2007 · 175 citations · Full text

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

, , +1

Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling

Joel Mermis, Haihua Gu, Bing Xue et al. · Respiratory Research · 2011 · 67 citations · Full text

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

Claire Keating, Lael M. Yonker, F. Vermeulen et al. · The Lancet Respiratory Medicine · 2025 · 62 citations · Full text

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Ahmet Uluer, Gordon MacGregor, Pilar Azevedo et al. · The Lancet Respiratory Medicine · 2023 · 61 citations · Full text

,

Rows per page

1–5 of 10